Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 26; no. 14; pp. 2578 - 2580
Main Authors Fasano, Alfonso, Di Matteo, Alessandro, Vitale, Carmine, Squintani, Giovanna, Ferigo, Laura, Bombieri, Federica, Santangelo, Gabriella, Amboni, Marianna, Barone, Paolo, Tinazzi, Michele
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.12.2011
Wiley
Subjects
Aged
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dopamine Agents - therapeutic use
Dyskinesia, Drug-Induced - etiology
Dystonia - chemically induced
Female
Humans
Indans - adverse effects
Male
Medical sciences
Middle Aged
Neurology
Neuroprotective Agents - adverse effects
Parkinson Disease - drug therapy
Human
Nervous system diseases
Treatment
Rasagiline
Central nervous system disease
Parkinson disease
Degenerative disease
Cerebral disorder
Extrapyramidal syndrome
Online AccessGet full text

Cover

More Information
Bibliography:ark:/67375/WNG-FGKVHDC2-D
Full financial disclosures and author roles may be found in the online version of this article.
Relevant conflicts of interest/financial disclosures: Nothing to report.
ArticleID:MDS23918
istex:3C339BD7EB82113F7A373F2915A002D9B1230B35
Nothing to report.
Alfonso Fasano and Alessandro Di Matteo contributed equally to this article.
Relevant conflicts of interest/financial disclosures
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.23918